Use of TNF alpha antagonists in refractory AIH: Revealing the unforeseen
| dc.creator | Saitis, A. | en |
| dc.creator | Gatselis, N. | en |
| dc.creator | Zachou, K. | en |
| dc.creator | Dalekos, G. N. | en |
| dc.date.accessioned | 2015-11-23T10:46:45Z | |
| dc.date.available | 2015-11-23T10:46:45Z | |
| dc.date.issued | 2013 | |
| dc.identifier.issn | 0168-8278 | |
| dc.identifier.uri | http://hdl.handle.net/11615/32764 | |
| dc.source.uri | <Go to ISI>://WOS:000320482100038 | |
| dc.subject | AUTOIMMUNE HEPATITIS | en |
| dc.subject | INFLIXIMAB | en |
| dc.subject | INDUCTION | en |
| dc.subject | MYCOPHENOLATE | en |
| dc.subject | DISEASE | en |
| dc.subject | SAFETY | en |
| dc.subject | Gastroenterology & Hepatology | en |
| dc.title | Use of TNF alpha antagonists in refractory AIH: Revealing the unforeseen | en |
| dc.type | journalArticle | en |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||